大理药业(603963)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603963 大理药业

已收盘 04-26 09:30:00

{"stockData":{"symbol":"603963","market":"SH","secType":"STK","nameCN":"大理药业","latestPrice":8.1,"timestamp":1714094940000,"preClose":8.1,"halted":0,"volume":0,"delay":0,"floatShares":220000000,"shares":220000000,"eps":-0.0984,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"04-26 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.0984,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":8.1,"symbolType":"stock","openAndCloseTimeList":[[1714095000000,1714102200000],[1714107600000,1714114800000]],"highLimit":8.91,"lowLimit":7.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":219700000,"pbRate":4.74,"roa":"--","roe":"--","epsLYR":-0.08,"marketValue":1780000000,"floatMarketCap":1780000000,"peRate":-82.317076,"changeRate":0,"turnoverRate":0,"status":2},"requestUrl":"/m/hq/s/603963","defaultTab":"news","newsList":[{"id":"2430237763","title":"图解大理药业一季报：第一季度单季净利润同比减110.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430237763","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430237763?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:59","pubTimestamp":1714067955,"startTime":"0","endTime":"0","summary":"证券之星消息，大理药业2024年一季报显示，公司主营收入1532.03万元，同比下降58.47%；归母净利润-537.5万元，同比下降110.65%；扣非净利润-658.41万元，同比下降74.41%；负债率18.55%，投资收益11.58万元，财务费用24.61万元，毛利率11.67%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600002719.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231242","title":"图解大理药业年报：第四季度单季净利润同比增25.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231242","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430231242?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:41","pubTimestamp":1714063284,"startTime":"0","endTime":"0","summary":"证券之星消息，大理药业2023年年报显示，公司主营收入8727.0万元，同比下降34.06%；归母净利润-2003.14万元，同比下降13.16%；扣非净利润-2522.39万元，同比下降7.58%；其中2023年第四季度，公司单季度主营收入1399.67万元，同比下降56.11%；单季度归母净利润-464.24万元，同比上升25.42%；单季度扣非净利润-581.5万元，同比上升25.09%；负债率19.57%，投资收益51.47万元，财务费用160.68万元，毛利率41.59%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600502687b00674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600502687b00674&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430806552","title":"大理药业：4月29日开市起复牌并实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2430806552","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2430806552?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:53","pubTimestamp":1714056784,"startTime":"0","endTime":"0","summary":"大理药业 （SH 603963，收盘价：8.1元）4月25日晚间发布公告称，公司股票将于2024年4月26日停牌1天，自2024年4月29日开市起复牌并实施退市风险警示，实施退市风险警示后，公司股票将在风险警示板交易，股票价格的日涨跌幅限制为5%。2023年1至12月份，大理药业的营业收入构成为：医药制造业占比98.03%，医药商业占比0.99%。大理药业的董事长、总经理均是杨君祥，男，62岁，学历背景为中专。截至发稿，大理药业市值为18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523002087afbd52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523002087afbd52&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430280658","title":"大理药业：业绩说明会定于5月8日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2430280658","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2430280658?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:41","pubTimestamp":1714056074,"startTime":"0","endTime":"0","summary":"每经AI快讯， 大理药业 （SH 603963，收盘价：8.1元）4月25日晚间发布公告称，公司2023年度暨2024年第一季度业绩说明会定于2024年5月8日下午16:00-17:00，以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有：董事长兼总经理杨君祥，副总经理兼财务总监李绍云，董事会秘书吴佩容，独立董事姚荣辉，李玉兰，董全亮。2023年1至12月份，大理药业的营业收入构成为：医药制造业占比98.03%，医药商业占比0.99%。大理药业的董事长、总经理均是杨君祥，男，62岁，学历背景为中专。截至发稿，大理药业市值为18亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522510487afb3b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522510487afb3b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430587408","title":"大理药业(603963.SH)发布一季度业绩 净亏损537.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430587408","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430587408?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:45","pubTimestamp":1714041957,"startTime":"0","endTime":"0","summary":"智通财经APP讯，大理药业(603963.SH)披露2024年第一季度报告，该公司报告期实现营业收入1532.03万元，同比下降58.47%。归属于上市公司股东的净亏损537.50万元，归属于上市公司股东的扣除非经常性损益的净亏损658.41万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110213.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430847711","title":"大理药业最新公告：一季度净亏损537.5万元 公司股票被实施退市风险警示并停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2430847711","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430847711?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:30","pubTimestamp":1714041043,"startTime":"0","endTime":"0","summary":"大理药业披露2024年第一季度报告，实现营业收入1532.03万元，同比下降58.47%；归母净利润-537.5万元。同日披露公司股票被实施退市风险警示暨停牌的公告，公司股票将于4月26日停牌1天，自4月29日开市起复牌并实施退市风险警示，实施退市风险警示后，公司股票将在风险警示板交易，股票价格的日涨跌幅限制为5%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500039280.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430408472","title":"被实施退市风险警示 大理药业4月26日停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2430408472","media":"北京商报","top":-1,"share":"https://www.laohu8.com/m/news/2430408472?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:27","pubTimestamp":1714040820,"startTime":"0","endTime":"0","summary":"4月25日晚间，大理药业（603963）发布公告称，因公司2023年度经审计的扣除非经常性损益前后的净利润均为负值，且扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于1亿元，公司股票将被实施退市风险警示。大理药业表示，公司股票将于4月26日停牌1天，自4月29日开市起复牌并实施退市风险警示，股票简称由“大理药业”变更为“*ST大药”。（文章来源：北京商报）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042518284687aed5ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042518284687aed5ec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430411702","title":"大理药业股价大幅上涨 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2430411702","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2430411702?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:37","pubTimestamp":1714009074,"startTime":"0","endTime":"0","summary":"04月25日，大理药业股价大幅上涨，截至09点37分，大理药业上涨5.06%，报8.31元/股，成交2850万元，换手率1.60%，振幅5.94%。资金动向截止发稿，大理药业获得主力净流入22万元，其中超大单流入69万元，大单流出47万元。主营业务及业绩大理药业公司主营业务为中西药注射剂的生产与销售。最新财报显示，今年三季报，大理药业实现营业收入7,327.32万元，同比减少27.06%，净利润为-1,538.90万元，同比减少34.08%，基本每股收益为-0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425093802792330d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240425093802792330d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429173671","title":"大理药业大幅下跌 主力净流出35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429173671","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429173671?lang=zh_cn&edition=full","pubTime":"2024-04-24 09:31","pubTimestamp":1713922281,"startTime":"0","endTime":"0","summary":"04月24日，大理药业股价大幅下跌，截至09点31分，大理药业下跌5.24%，报7.41元/股，成交361万元，换手率0.21%，振幅5.37%。资金动向截止发稿，大理药业获得主力净流出35万元。数据显示，该股今日净流入较近5日净流入均值减少3万元。主营业务及业绩大理药业公司主营业务为中西药注射剂的生产与销售。最新财报显示，今年三季报，大理药业实现营业收入7,327.32万元，同比减少27.06%，净利润为-1,538.90万元，同比减少34.08%，基本每股收益为-0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240932397a550a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240932397a550a6e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429969714","title":"大理药业大跌5.23% 面临退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2429969714","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2429969714?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:32","pubTimestamp":1713749564,"startTime":"0","endTime":"0","summary":"04月22日，大理药业股价大幅下跌，截至09点32分，大理药业下跌5.23%，报8.15元/股，成交1045万元，换手率0.58%。按照《上海证券交易所股票上市规则》，大理药业公司股票在2023年年度报告披露后，可能被实施退市风险警示。大理药业业绩预告披露，2023年公司经营业绩同比增亏的主要原因是：受中成药集中带量采购的影响，公司主营产品销售价格和销量均有所下滑，毛利减少。因此，大理药业股票面临被实施退市风险警示。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220943567a545ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220943567a545ca5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428644019","title":"中药注射液企业大理药业或被实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2428644019","media":"中国经营网","top":-1,"share":"https://www.laohu8.com/m/news/2428644019?lang=zh_cn&edition=full","pubTime":"2024-04-20 16:53","pubTimestamp":1713603181,"startTime":"0","endTime":"0","summary":"2023年年报披露前，中药注射液企业大理药业股价大起大落。按照《上海证券交易所股票上市规则》，大理药业公司股票在2023年年度报告披露后，可能被实施退市风险警示。因此，大理药业股票面临被实施退市风险警示。同期，大理药业的销售费用却一直保持较高水平。多年来，大理药业研发人员一直仅有8名。而大理药业3个规格均仅为备选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404201659148799383a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404201659148799383a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428750842","title":"大理药业股价大幅上涨 获主力净流入355万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428750842","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2428750842?lang=zh_cn&edition=full","pubTime":"2024-04-19 11:03","pubTimestamp":1713495785,"startTime":"0","endTime":"0","summary":"04月19日，大理药业股价大幅上涨，截至11点03分，大理药业上涨5.11%，报8.64元/股，成交9212万元，换手率4.97%。资金动向截止发稿，大理药业获得主力净流入355万元，其中超大单流入237万元，大单流入117万元。融资融券方面，大理药业04月17日获得融资净买入86万元，当日该股融资余额为1471万元，当较前一日增加6.21%。此外，大理药业04月18日上榜龙虎榜。主营业务及业绩大理药业公司主营业务为中西药注射剂的生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191103147921b630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191103147921b630&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428561870","title":"大理药业龙虎榜:营业部净卖出510.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428561870","media":"证券时报","top":-1,"share":"https://www.laohu8.com/m/news/2428561870?lang=zh_cn&edition=full","pubTime":"2024-04-18 18:04","pubTimestamp":1713434667,"startTime":"0","endTime":"0","summary":"上交所公开信息显示，当日该股因日振幅值达16.89%上榜，营业部席位合计净卖出510.21万元。证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交3724.96万元，其中，买入成交额为1607.37万元，卖出成交额为2117.59万元，合计净卖出510.21万元。具体来看，今日上榜营业部中，第一大买入营业部为国泰君安证券股份有限公司总部，买入金额为441.87万元，第一大卖出营业部为川财证券有限责任公司武汉沿江大道证券营业部，卖出金额为915.59万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181804308b3585cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181804308b3585cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428814755","title":"中药行业盘中拉升，大理药业涨3.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428814755","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428814755?lang=zh_cn&edition=full","pubTime":"2024-04-18 10:52","pubTimestamp":1713408729,"startTime":"0","endTime":"0","summary":"04月18日，中药行业盘中拉升，截至10点52分，中药行业整体指数上涨1.00%，报6985.480点。从个股上来看，该行业的成分股中，大理药业涨3.92%，东阿阿胶、天士力、华润三九涨幅居前。从资金上来看，截止发稿，中药行业主力净流入为-1.75亿，其中佐力药业受到资金热捧，主力净流入1203.54万；拉长时间线来看，该板块近20日主力资金净流入-55.42亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418105209861e6f8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418105209861e6f8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428886605","title":"大理药业大幅下跌 主力净流出187万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428886605","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2428886605?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:30","pubTimestamp":1713403845,"startTime":"0","endTime":"0","summary":"04月18日，大理药业股价大幅下跌，截至09点30分，大理药业下跌5.26%，报7.74元/股，成交1687万元，换手率0.95%，振幅5.51%。资金动向截止发稿，大理药业获得主力净流出187万元，其中超大单流入38万元，大单流出225万元。此外，大理药业04月17日上榜龙虎榜。主营业务及业绩大理药业公司主营业务为中西药注射剂的生产与销售。最新财报显示，今年三季报，大理药业实现营业收入7,327.32万元，同比减少27.06%，净利润为-1,538.90万元，同比减少34.08%，基本每股收益为-0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809314879215c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041809314879215c7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428315056","title":"大理药业：二级市场股票价格波动受市场环境、宏观经济等多种因素的影响，请投资者理性投资，注意风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2428315056","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428315056?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:00","pubTimestamp":1713351640,"startTime":"0","endTime":"0","summary":"证券之星消息，大理药业(603963)04月17日在投资者关系平台上答复投资者关心的问题。投资者：公司股价连续一字跌停，公司股价被恶意做空，操纵股价，触发系统性风险，公司没有维护股价的动作吗？大理药业董秘：尊敬的投资者您好！二级市场股票价格波动受市场环境、宏观经济等多种因素的影响，请投资者理性投资，注意风险。非常感谢您对大理药业的关注与支持！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171902348b2ec18b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171902348b2ec18b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428680331","title":"云南板块盘中拉升，川金诺涨6.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428680331","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428680331?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:37","pubTimestamp":1713317870,"startTime":"0","endTime":"0","summary":"04月17日，云南板块盘中拉升，截至09点37分，云南板块整体指数上涨2.02%，报1735.140点。从个股上来看，该板块的成分股中，川金诺涨6.50%，我爱我家、大理药业等6只股涨幅超过5%。从资金上来看，截止发稿，云南板块主力净流入为-1616.87万，其中大理药业受到资金热捧，主力净流入1530.07万；拉长时间线来看，该板块近20日主力资金净流入-24.70亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709375087e81119&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709375087e81119&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428316513","title":"大理药业大跌5.52% 主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2428316513","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2428316513?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:30","pubTimestamp":1713317403,"startTime":"0","endTime":"0","summary":"04月17日，大理药业股价大幅下跌，截至09点30分，大理药业下跌5.52%，报7.02元/股，创近1月新低，成交2352万元，换手率1.57%，振幅3.77%。资金动向截止发稿，大理药业获得主力净流入1569万元，其中超大单流入1556万元，大单流入12万元。融资融券方面，大理药业04月15日获得融资净买入14万元，当日该股融资余额为1481万元，当较前一日增加1.02%。主营业务及业绩大理药业公司主营业务为中西药注射剂的生产与销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170932137a5346f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170932137a5346f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427780350","title":"大理药业：股票交易异常波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2427780350","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2427780350?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:23","pubTimestamp":1713176598,"startTime":"0","endTime":"0","summary":"大理药业 （SH 603963）4月15日晚间发布公告称，大理药业股份有限公司股票交易于2024年4月11日、2024年4月12日、2024年4月15日连续3个交易日收盘价格跌幅偏离值累计超过20%。经核实，截至本公告披露日，公司、控股股东及实际控制人均不存在应披露而未披露的重大信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415183050877f1a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415183050877f1a66&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-09-22","address":"云南省大理白族自治州大理市下关环城西路118号","stockEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":-0.3041},{"period":"3month","weight":-0.2256},{"period":"6month","weight":-0.2278},{"period":"1year","weight":-0.2528},{"period":"ytd","weight":-0.3182}],"companyName":"大理药业股份有限公司","boardCode":"AI0027","perCapita":"6155股","boardName":"医药制造业","registeredCapital":"21970万元","compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0071},{"period":"3month","weight":0.049},{"period":"6month","weight":0.0116},{"period":"1year","weight":-0.0647},{"period":"ytd","weight":0.0262}],"survey":"　　大理药业股份有限公司主营业务为中药注射剂的生产和销售。公司主要产品为“中精牌”醒脑静注射液和参麦注射液。“中精ZHONGJING及图”商标为中国驰名商标。","serverTime":1714119209027,"listedPrice":12.58,"stockholders":"35691人(较上一季度增加69.15%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大理药业(603963)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大理药业(603963)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大理药业,603963,大理药业股票,大理药业股票老虎,大理药业股票老虎国际,大理药业行情,大理药业股票行情,大理药业股价,大理药业股市,大理药业股票价格,大理药业股票交易,大理药业股票购买,大理药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大理药业(603963)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大理药业(603963)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}